PLOD1 and cancer: On the contrary, LH of the protective and therapeutic groups was significantly elevated to 37.67 ± 2.32 and 36.02 ± 2.43 ng/mL after 90 days compared to the cancer control (28.00 ± 1.84 ng/mL).